Featured news
-
Genomic study helps detect baby’s rare growth condition
Baby Safi started treatment for a rare growth condition after participating in the Generation Study, a national genomic screening study
-
Rare Disease Day (28 Feb) is nearly here
Rare Disease Day is a globally coordinated movement dedicated to rare diseases, striving for equity in social opportunities, healthcare, and access to diagnosis and therapies for people living with a rare disease.
-
Genomics Primer4Pharmacy course
We have an exciting opportunity for those working in pharmacy in the East Genomics region (East Midlands and East of England) to attend a one day Genomics Primer4Pharmacy course.
-
Public and patient involvement opportunities
Here are details of a couple of great opportunities for patients and the public in the East Midlands and East of England to get involved and help shape decisions about genomics in our region.
-
National Cancer Plan launched
The National Cancer Plan, launched on 4 February 2026, sets out England’s next major phase of change to improve cancer outcomes over the coming decade.
-
Leukaemia testing in Leicester helps patients to access tailored treatments
By offering IDH1 testing in AML, the lab are helping people to access targeted treatments sooner
All news
Showing 20 results
Nursing and midwifery team appointed to help peers across the region take a proactive role in genomic medicine
The recently appointed nursing and midwifery staff at East Genomics are an essential part of the strategic team to support the mainstreaming of genomic medicine into clinical practice across the East of England and East Midlands to help improve patient care and outcomes.
New genomic testing provides vital diagnosis for severely ill babies
Cambridge research suggests more than a third of severely sick babies given rapid whole genome sequencing have received a vital genetic diagnosis.
More than 100 children with cancer across the East of England benefit from whole genome sequencing
In a significant milestone, more than 100 children with cancer from across the East of England have had their tumours tested by whole genome sequencing (WGS) and interpreted by scientists in the NHS Genomic Medicine Service at Cambridge University Hospitals NHS Foundation Trust (CUH), to help improve their diagnosis and treatment.
Largest study of whole genome sequencing data reveals new causes of cancer
Cambridge analysis of more than 12,000 tumours from NHS patients has found DNA evidence of over 50 new potential causes of cancer.
Revolutionary new treatment path for patients with aggressive brain tumours
Brain tumour patients at Addenbrooke’s Hospital in Cambridge are the first in the UK to benefit from personalised treatment using the latest advances in genomics and targeted therapies through the Minderoo Foundation's new Precision Brain Tumour Programme (MPBTP).
Genetic testing for Lynch syndrome help patients and clinicians fight cancer
Awareness of this inherited condition can help patients alert relatives to get tested and it can also ensure suitable screening and preventative treatment for future cancers
With a history of cancer in the family, Marla's story highlights how a Lynch syndrome diagnosis has helped her
Marla explains how she can look forward and concentrate on the prevention of cancer for herself and her family since her Lynch syndrome diagnosis
Genetic study gives new insights into severe Covid
The world’s largest genetic study of critically-ill Covid patients, involving more than 200 treated at Addenbrooke's, reveals extensive insights into the disease.
Family share Eilidh's story on Rare Disease Day
Raising a child with a rare or little understood condition is a major challenge for parents.
E-learning modules launched to help clinicians across the region order genomic tests for patients
Clinical Geneticists and Genetic Counsellors at Cambridge University Hospitals (CUH) have developed several short e-learning modules to help healthcare professionals across the East of England and East Midlands offer genomic testing to patients.
Cambridge clinician wins funding to safely link big datasets to help find medical answers
Cambridge researchers are to trial methods of analysing data across more than one secure research environment – something which has previously not been possible, but which could be of great benefit to the public once established.
Whole genome sequencing improves diagnosis of rare diseases and shortens diagnostic journeys for patients, according to world first study
A world-first scientific study has shown that whole genome sequencing (WGS) can uncover new diagnoses for people across the broadest range of rare diseases investigated to date
Whole Genome Sequencing helps doctors treat Daniel’s rare cancer
Sport-loving schoolboy Daniel is back on the football pitch following precision treatment of a rare kidney tumour
Serena Nik-Zainal wins top prize for ground-breaking research into cancer
Professor Serena Nik-Zainal has been announced as the winner of the 2021 Foulkes Foundation Academy of Medical Sciences Medal
Regional Genomics Survey - deadline extended!
Regional survey launched to gain insight into healthcare professionals knowledge and use of genomic testing
National Genomic Test Directory update
On 4 October, updates to the National Genomics Test Directory were made live on the NHS England website.
National blood tube shortage
Due to the national blood tube shortage, all NHS Trusts are requested to continue to reduce testing by 25% until Friday 8 October.
Multi-award winning Jean-Christophe Novelli reveals how genomic testing helped his family
Jean-Christophe Novelli and his wife Michelle spoke today at East GLH of how genomic testing for their son Valentino helped them find the right treatment and plan their future life.
East GLH ready to deliver higher volume of rapid genomic testing
We are extremely proud to have now completed major building works at our lead laboratory based at Cambridge University Hospitals NHS Foundation Trust which will help us deliver an enhanced genomic service for the East of England and East Midlands.
Genome sequencing hope for families seeking diagnoses and treatment for rare disease
Thanks to whole genome sequencing, doctors were able to diagnose Eleanor quickly